Get the Stockscreener App
11.03
1.38%
+0.15
Pre-market:
11.45
0.42
+3.81%
Roivant Sciences Ltd Stock (ROIV) Forecast
The Roivant Sciences Ltd (ROIV) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $8.9772, representing a -18.61% decrease from the current price of $11.03. The highest analyst price target is $10.19, and the lowest is $7.7641.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ROIV Price Target
Average 9.1571
(-16.98% Downside)
Is Roivant Sciences Ltd (ROIV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.26 | Neutral |
| STOCH(9,6) | 58.71 | Neutral |
| STOCHRSI(14) | 76.67 | Neutral |
| MACD(12,26) | 0.00564 | Buy |
| ADX(14) | 14.44 | Neutral |
| William %R | -45.16 | Neutral |
| CCI(14) | 44.84 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
10.72
Buy
|
10.84
Buy
|
| MA20 |
10.98
Buy
|
10.84
Buy
|
| MA50 |
10.94
Buy
|
10.81
Buy
|
| MA100 |
10.79
Buy
|
10.69
Buy
|
| MA200 |
10.64
Buy
|
10.28
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ROIV could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 0 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on ROIV, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.26 indicates that ROIV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 58.71 indicates that ROIV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 76.67 indicates that ROIV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.44 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 44.84 indicates that ROIV is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ROIV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Roivant Sciences Ltd financial reports and earnings history, Roivant Sciences Ltd (ROIV) stock could reach $15.57 by 2030, $33.53 by 2040 and $46.87 by 2050. See the projected annual prices until 2050 of the Roivant Sciences Ltd stock below:
- Roivant Sciences Ltd (ROIV) is expected to reach an average price of $23.97 in 2035, with a high prediction of $24.18 and a low estimate of $21.20. This indicates an $117.33% rise from the last recorded price of $11.03.
- Roivant Sciences Ltd (ROIV) stock is projected to chart a bullish course in 2040, with an average price target of $32.37, representing an $193.46% surge from its current level. The forecast ranges from a conservative $29.80 to a sky-high $33.53.
- Our analysts predict Roivant Sciences Ltd (ROIV) to jump 256.34% by 2045, soaring from $38.01 to an average price of $39.30, potentially reaching $39.65. While $38.01 is the low estimate, the potential upside is significant.
- Roivant Sciences Ltd (ROIV) stock is expected to climb by 2050, reaching an average of $46.64, a $322.83% jump from its current level. However, a wide range of estimates exists, with high and low targets of $46.87 and $45.27, respectively, highlighting the market's uncertainty.
Roivant Sciences Ltd Stock (ROIV) Year by Year Forecast
Roivant Sciences Ltd Stock (ROIV) Price Forecast for 2024
Our forecast for ROIV stock price in 2024 now indicates an average price target of $12.59 with a high forecast of $19.62 and a low forecast of $5.5653. The average prediction reflects an increase of +14.18% from the last recorded price of $11.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $8.1641 | $7.7641 | $10.19 | -25.98% |
| June, 2024 | $7.1557 | $7.0457 | $8.662 | -35.12% |
| July, 2024 | $6.5053 | $5.5653 | $7.2395 | -41.02% |
| August, 2024 | $7.437 | $6.4332 | $7.587 | -32.58% |
| September, 2024 | $7.5365 | $6.5328 | $7.9986 | -31.67% |
| October, 2024 | $7.1282 | $7.0882 | $7.9845 | -35.37% |
| November, 2024 | $6.9298 | $6.7398 | $7.714 | -37.17% |
| December, 2024 | $6.2094 | $6.0894 | $7.0915 | -43.70% |
Roivant Sciences Ltd Stock (ROIV) Price Forecast for 2025
Roivant Sciences Ltd Stock (ROIV) is expected to reach an average price of $10.89 in 2025, with a high prediction of $15.62 and a low estimate of $6.1473. This indicates an -1.31% fall from the last recorded price of $11.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.6911 | $6.1473 | $8.0011 | -30.27% |
| February, 2025 | $8.4427 | $7.359 | $9.0027 | -23.46% |
| March, 2025 | $10.32 | $8.0085 | $10.43 | -6.42% |
| April, 2025 | $12.60 | $9.7681 | $12.75 | +14.27% |
| May, 2025 | $11.69 | $11.48 | $13.36 | +5.94% |
| June, 2025 | $11.52 | $10.86 | $12.37 | +4.40% |
| July, 2025 | $10.38 | $10.04 | $12.39 | -5.92% |
| August, 2025 | $12.45 | $10.38 | $12.47 | +12.86% |
| September, 2025 | $12.84 | $11.56 | $13.38 | +16.39% |
| October, 2025 | $13.21 | $12.31 | $13.64 | +19.76% |
| November, 2025 | $15.26 | $11.99 | $15.59 | +38.36% |
| December, 2025 | $15.20 | $14.17 | $15.62 | +37.81% |
Roivant Sciences Ltd Stock (ROIV) Price Forecast for 2026
The predicted value for Roivant Sciences Ltd (ROIV) in 2026 is set at an average of $16.08. Estimates vary from a peak of $22.49 to a trough of $9.6782, indicating an +45.81% surge from the present price of $11.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.34 | $13.88 | $15.60 | +39.10% |
| February, 2026 | $15.37 | $13.56 | $16.93 | +39.39% |
| March, 2026 | $12.37 | $11.97 | $15.35 | +12.18% |
| April, 2026 | $12.90 | $12.22 | $13.36 | +16.91% |
| May, 2026 | $14.96 | $12.38 | $15.14 | +35.60% |
| June, 2026 | $12.65 | $12.51 | $15.07 | +14.66% |
| July, 2026 | $16.66 | $12.21 | $17.20 | +51.05% |
| August, 2026 | $13.04 | $12.62 | $22.49 | +18.22% |
| September, 2026 | $12.70 | $12.33 | $13.94 | +15.17% |
| October, 2026 | $11.58 | $11.01 | $13.14 | +4.96% |
| November, 2026 | $10.84 | $10.49 | $11.64 | -1.76% |
| December, 2026 | $9.749 | $9.6782 | $10.80 | -11.61% |
Roivant Sciences Ltd Stock (ROIV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Roivant Sciences Ltd (ROIV) is $12.67, with a high forecast of $16.72 and a low forecast of $8.6106. This indicates an +14.84% increase from the last price of $11.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.16 | $8.6106 | $10.32 | -7.87% |
| February, 2027 | $10.57 | $9.6256 | $10.73 | -4.21% |
| March, 2027 | $10.53 | $10.23 | $11.11 | -4.49% |
| April, 2027 | $10.70 | $9.9172 | $10.88 | -3.01% |
| May, 2027 | $10.02 | $9.5072 | $10.67 | -9.18% |
| June, 2027 | $10.87 | $9.3088 | $11.07 | -1.45% |
| July, 2027 | $11.67 | $10.60 | $11.82 | +5.84% |
| August, 2027 | $11.97 | $11.31 | $12.29 | +8.55% |
| September, 2027 | $13.69 | $11.87 | $14.19 | +24.08% |
| October, 2027 | $15.52 | $13.36 | $16.72 | +40.70% |
| November, 2027 | $15.44 | $14.26 | $15.78 | +39.97% |
| December, 2027 | $14.53 | $14.38 | $15.62 | +31.75% |
Roivant Sciences Ltd Stock (ROIV) Price Forecast for 2028
In 2028, Roivant Sciences Ltd (ROIV) is projected to reach an average price of $17.06, with a high projection of $20.63 and a low estimate of $13.50. This indicates an +54.70% rise from the last price of $11.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $14.07 | $13.50 | $15.83 | +27.57% |
| February, 2028 | $16.13 | $14.58 | $16.52 | +46.28% |
| March, 2028 | $16.53 | $15.57 | $16.91 | +49.84% |
| April, 2028 | $17.23 | $15.56 | $17.97 | +56.22% |
| May, 2028 | $19.21 | $16.86 | $19.22 | +74.16% |
| June, 2028 | $18.43 | $17.52 | $19.25 | +67.12% |
| July, 2028 | $17.70 | $17.33 | $20.20 | +60.50% |
| August, 2028 | $17.10 | $16.95 | $20.63 | +54.99% |
| September, 2028 | $16.31 | $15.70 | $17.48 | +47.86% |
| October, 2028 | $17.41 | $15.98 | $17.62 | +57.83% |
| November, 2028 | $16.82 | $15.84 | $18.93 | +52.53% |
| December, 2028 | $17.50 | $15.04 | $18.29 | +58.65% |
Roivant Sciences Ltd Stock (ROIV) Price Forecast for 2029
The 2029 price forecast for Roivant Sciences Ltd Stock (ROIV) is $18.50 on average, with a high prediction of $25.35 and a low estimate of $11.66. This represents an +67.75% increase from the previous price of $11.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $17.19 | $16.59 | $25.35 | +55.82% |
| February, 2029 | $15.68 | $15.23 | $17.36 | +42.18% |
| March, 2029 | $15.41 | $15.07 | $16.22 | +39.69% |
| April, 2029 | $13.93 | $13.68 | $16.09 | +26.26% |
| May, 2029 | $13.09 | $12.77 | $14.09 | +18.64% |
| June, 2029 | $12.60 | $11.66 | $13.30 | +14.20% |
| July, 2029 | $13.12 | $12.54 | $13.74 | +18.99% |
| August, 2029 | $13.77 | $12.72 | $14.22 | +24.84% |
| September, 2029 | $13.42 | $13.38 | $14.23 | +21.71% |
| October, 2029 | $13.12 | $12.99 | $14.04 | +18.98% |
| November, 2029 | $12.65 | $12.53 | $13.51 | +14.67% |
| December, 2029 | $15.03 | $12.60 | $15.08 | +36.24% |
Roivant Sciences Ltd Stock (ROIV) Price Forecast for 2030
Roivant Sciences Ltd Stock (ROIV) is expected to reach an average price of $19.12 in 2030, with a high forecast of $23.63 and a low forecast of $14.61. This signifies an +73.33% surge from the last price of $11.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $14.87 | $14.67 | $15.57 | +34.83% |
| February, 2030 | $16.97 | $14.61 | $17.08 | +53.82% |
| March, 2030 | $19.31 | $16.44 | $19.46 | +75.08% |
| April, 2030 | $17.98 | $17.65 | $20.09 | +63.01% |
| May, 2030 | $18.37 | $17.70 | $19.19 | +66.50% |
| June, 2030 | $17.29 | $16.96 | $19.28 | +56.76% |
| July, 2030 | $19.04 | $17.31 | $19.48 | +72.61% |
| August, 2030 | $19.89 | $18.57 | $20.43 | +80.36% |
| September, 2030 | $20.50 | $19.42 | $21.53 | +85.88% |
| October, 2030 | $21.89 | $19.14 | $22.80 | +98.44% |
| November, 2030 | $22.46 | $21.39 | $22.87 | +103.65% |
| December, 2030 | $23.61 | $21.16 | $23.63 | +114.07% |
1.53%
3.38%
Cap:
|
Volume (24h):